Since 2009, CPRIT has awarded more than $1.35 billion in grants to Texas researchers, institutions and organizations. CPRIT provides funding through its academic research, prevention and product development research programs. Programs made possible with CPRIT funding have reached all 254 counties of the state, brought nearly 100 distinguished researchers to Texas, advanced scientific and clinical knowledge, and provided more than 2.5 million life-saving education, training, prevention and early detection services to Texans.
Following an overview of CPRIT's funding opportunities and key areas of interest, don't miss the opportunity to introduce yourself during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with CPRIT will provide a forum to further discuss your company.
10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
1:00-5:00pm | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on September 23rd, 2016.
CPRIT Participating Representative:
Michael Lang | Chief Product Development Research Officer, CPRIT
Mike Lang leads CPRIT's product development research program, designed to accelerate the progression of new cancer drugs, diagnostics, and therapies from the laboratory into clinical practice. His multi-state experience includes founding and serving as chief executive officer of a cancer diagnostic company, serial entrepreneurship, and managing a portfolio for an early stage investment. Prior to joining CPRIT in November 2015, Lang was the founder and CEO of NanoVision, a cancer diagnostics company. He headed business development at the venture capital-funded wound healing company Gilatech, where he led its novel biomaterial therapy. Lang oversaw a company restructuring as president of Dallas-based Galt Medical, served as a product manager at Johnson & Johnson, and was vice president of business development at BioEnterprise, where he directed the startup and growth of early stage firms. Lang has a bachelor's in biomedical engineering from Northern Arizona University and a master's in business administration from Arizona State University.
Connect with CPRIT:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until noon on October 11th, 2016 (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on September 23rd, 2016. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.
About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
JLABS @ TMC
John P. McGovern Campus
2450 Holcombe Blvd, Suite J
Houston, TX 77021
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.
When & Where
JLABS @ TMC
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.